LegislativeLabs.ai Logo
Legislative Labs
  • See through the fog of Legislation.
    • FAQ

      Help using Legislative Labs
    • Support

      Contact us for assistance.
    • Legal

      Terms & Conditions.
    • Privacy

      What we do with your information.
    • Sign Up

      Join Legislative Labs to unlock live predictions.
    • Analytics

      Intelligence & analytics on previous sessions.
    • Bill History

      Detailed historical bill information.
    • Sponsor Detail

      Detailed sponsor bill performance.
    • About Us

      The reason for Legislative Labs.
    • startupgrind

      Event overview and demo information.
    • BETA

      Session Dashboard

      Live predictions on introduced legislation.
    • BETA

      Bill Drafting

      Predictions on draft legislation.
    • BETA

      Legitron AI

      Legislation made simple with AI.
    • Session Results

      Legislative session analytics.
    • Sign in

ESHB 2196 Information

Legal Title AN ACT Relating to expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome;
Description Expanding access to PANDA PANS treatment.

Details

Date Introduced 02/03/2026
Original Chamber House
Biennium 2025-26
Total Campaign Dollars Backing Bill $983,832.19

Bill Topics

HEALTH INSURANCE

Sponsors

Representative Simmons (Primary)
Representative Low
Representative Leavitt
Representative Paul
Representative Nance
Representative Duerr
Representative Stonier
Representative Couture
Representative Davis
Representative Stuebe
Representative Lekanoff

Committee Hearings

Hearing House Health Care & Wellness (Public)
Hearing House Health Care & Wellness (Executive)

ESHB 2196 Bill Timeline

Go to ESHB 2196 at leg.wa.gov
Introduced
03/12/2026
HRules 3C
By resolution, returned to House Rules Committee for third reading.
02/18/2026
HRules 3C
First reading, referred to Health & Long-Term Care.
02/16/2026
HRules 3C
1st substitute bill substituted.
02/16/2026
HRules 3C
Floor amendment(s) adopted.
02/16/2026
HRules 3C
Rules suspended. Placed on Third Reading.
02/16/2026
HRules 3C
Third reading, passed; yeas, 83; nays, 13; absent, 0; excused, 2.
02/14/2026
HRules 3C
Rules Committee relieved of further consideration. Placed on second reading.
02/04/2026
HRules 3C
Referred to Rules 2 Review.
02/03/2026
Hsubst for
HCW - Executive action taken by committee.
02/03/2026
HRules 3C
HCW - Majority; 1st substitute bill be substituted, do pass.
02/03/2026
HRules 3C
Minority; do not pass.
02/03/2026
HRules 3C
Minority; without recommendation.
01/12/2026
Hsubst for
First reading, referred to Health Care & Wellness.
12/24/2025
Hsubst for
Prefiled for introduction.

You have 3 pending action.

Legitron™ is a trademark of Legislative Labs, Inc.

© 2026 - Legislative Labs